Healthpeak Swings to Loss Amid JV Setbacks, Asset Sales Decline

Ticker: DOC · Form: 10-Q · Filed: Oct 24, 2025 · CIK: 765880

Healthpeak Properties, INC. 10-Q Filing Summary
FieldDetail
CompanyHealthpeak Properties, INC. (DOC)
Form Type10-Q
Filed DateOct 24, 2025
Risk Levelhigh
Pages16
Reading Time19 min
Key Dollar Amounts$1.00
Sentimentbearish

Sentiment: bearish

Topics: REIT, Healthcare Real Estate, Net Loss, Joint Ventures, Asset Sales, Debt Increase, Financial Performance

Related Tickers: DOC, PEAK

TL;DR

**Healthpeak's massive Q3 loss and declining asset sales are a red flag; time to re-evaluate your DOC position.**

AI Summary

Healthpeak Properties, Inc. (DOC) reported a significant net loss of $117.1 million for the three months ended September 30, 2025, a stark contrast to the net income of $85.9 million in the same period of 2024. For the nine months ended September 30, 2025, the company recorded a net loss of $42.6 million, compared to a net income of $238.6 million in the prior year. Total revenues saw a modest increase to $705.9 million for the three months ended September 30, 2025, up from $700.4 million in 2024, and to $2.10 billion for the nine months, up from $2.00 billion. This revenue growth was primarily driven by increased resident fees and services, which rose to $150.5 million from $142.8 million for the quarter. A major factor in the net loss was a substantial equity loss from unconsolidated joint ventures, totaling $176.3 million for the quarter and $176.7 million for the nine months, compared to minimal losses in the prior year periods. The company also experienced a significant decrease in gain on sales of real estate, dropping to $11.5 million from $62.3 million for the quarter. Total assets decreased to $19.58 billion from $19.94 billion at December 31, 2024, while total liabilities increased to $11.32 billion from $10.88 billion, largely due to increased bank line of credit and commercial paper borrowings and senior unsecured notes. Cash and cash equivalents declined to $91.0 million from $119.8 million.

Why It Matters

Healthpeak's shift from profit to a substantial net loss, driven by significant equity losses from joint ventures and reduced real estate sale gains, signals potential headwinds for investors. The increase in debt and decline in cash could impact future growth initiatives and dividend sustainability, especially in a competitive healthcare real estate market. This performance could pressure DOC's stock price and may lead to a re-evaluation of its investment strategy by institutional and retail investors. For employees and customers, a less financially robust company might mean slower expansion or reduced investment in property upgrades, potentially affecting service quality or job security. The broader market may see this as a cautionary tale for REITs heavily reliant on joint ventures and asset dispositions for profitability, particularly in a fluctuating interest rate environment.

Risk Assessment

Risk Level: high — The company reported a net loss of $117.1 million for the three months ended September 30, 2025, a significant decline from a net income of $85.9 million in the prior year. This was largely driven by a substantial equity loss from unconsolidated joint ventures of $176.3 million, compared to a loss of only $3.8 million in the same period last year, and a sharp decrease in gain on sales of real estate from $62.3 million to $11.5 million. Total liabilities also increased by $436.5 million to $11.32 billion, while total equity decreased by $817.5 million to $8.24 billion, indicating a weakening financial position.

Analyst Insight

Investors should consider reducing their exposure to Healthpeak Properties (DOC) given the significant net loss, substantial equity losses from joint ventures, and declining gains from real estate sales. A deeper dive into the specific joint venture underperformances and the company's debt management strategy is warranted before considering any new investment.

Financial Highlights

debt To Equity
1.37
revenue
$705.9M
operating Margin
N/A
total Assets
$19.58B
total Debt
$8.5B
net Income
$(117.1)M
eps
$(0.17)
gross Margin
N/A
cash Position
$91.0M
revenue Growth
+0.8%

Revenue Breakdown

SegmentRevenueGrowth
Rental and related revenues$539,886,000-0.6%
Resident fees and services$150,458,000+5.3%
Interest income and other$15,529,000+8.6%

Key Numbers

Key Players & Entities

FAQ

What caused Healthpeak Properties' net loss in Q3 2025?

Healthpeak Properties reported a net loss of $117.1 million for the three months ended September 30, 2025, primarily due to a substantial equity loss of $176.3 million from unconsolidated joint ventures and a significant decrease in gain on sales of real estate to $11.5 million from $62.3 million in the prior year.

How did Healthpeak Properties' revenue perform in Q3 2025?

Healthpeak Properties' total revenues increased slightly to $705.9 million for the three months ended September 30, 2025, up from $700.4 million in the same period of 2024. This modest growth was mainly driven by an increase in resident fees and services.

What is the current debt situation for Healthpeak Properties?

Healthpeak Properties' total liabilities increased to $11.32 billion as of September 30, 2025, from $10.88 billion at December 31, 2024. This increase was largely attributed to higher borrowings under the bank line of credit and commercial paper, which rose to $368.1 million from $150.0 million, and an increase in senior unsecured notes to $6.77 billion from $6.56 billion.

What impact did the Physicians Realty Trust merger have on Healthpeak Properties?

The merger with Physicians Realty Trust was completed on March 1, 2024. While the filing doesn't detail specific Q3 2025 impacts, the merger was a significant event in the prior year, influencing the company's overall structure and financial base, as seen in the 'Shares issued as part of the Merger' in the equity statements for the nine months ended September 30, 2024.

What are the key risks highlighted in Healthpeak Properties' 10-Q?

The 10-Q indicates a high risk level due to the significant net loss of $117.1 million, substantial equity losses from unconsolidated joint ventures ($176.3 million), and a sharp decline in gains from real estate sales ($11.5 million compared to $62.3 million). These factors suggest potential operational and financial challenges.

How has Healthpeak Properties' cash position changed?

Healthpeak Properties' cash and cash equivalents decreased to $91.0 million as of September 30, 2025, from $119.8 million at December 31, 2024. Net cash provided by operating activities for the nine months ended September 30, 2025, was $957.9 million, but this was offset by significant cash used in investing and financing activities.

What is Healthpeak Properties' strategic outlook given these results?

While the filing doesn't explicitly state a revised strategic outlook, the financial results suggest a need for re-evaluation of joint venture performance and asset disposition strategies. The company's focus on healthcare discovery and delivery in the U.S. remains, but the significant losses may prompt adjustments to capital allocation and investment priorities.

What is Healthpeak Properties' dividend policy?

Healthpeak Properties paid common dividends of $0.305 per share for the three months ended September 30, 2025, totaling $212.1 million. For the nine months ended September 30, 2025, common dividends were $0.915 per share, totaling $637.9 million. The sustainability of future dividends may be scrutinized given the recent net losses.

What accounting changes did Healthpeak Properties adopt recently?

Healthpeak Properties adopted ASU No. 2023-07, Segment Reporting, retrospectively during the year ended December 31, 2024. This update aims to improve reportable segment disclosures but did not have an impact on the company's consolidated financial position, results of operations, or cash flows.

What does 'equity income (loss) from unconsolidated joint ventures' mean for Healthpeak Properties?

This line item represents Healthpeak Properties' share of the net income or loss from joint ventures where the company does not have controlling interest. A significant loss, such as the $176.3 million reported for Q3 2025, indicates that these joint ventures performed poorly and negatively impacted Healthpeak's overall profitability.

Risk Factors

Industry Context

Healthpeak Properties operates in the healthcare real estate sector, which is influenced by demographic trends, healthcare utilization, and reimbursement policies. The sector includes medical office buildings, life science facilities, and senior housing. Competition is driven by property location, tenant quality, and the ability to secure long-term leases.

Regulatory Implications

As a healthcare REIT, Healthpeak is subject to regulations impacting healthcare providers, such as HIPAA, and real estate investment trust (REIT) rules. Changes in healthcare policy or tax laws could affect tenant demand and the company's operating costs and profitability.

What Investors Should Do

  1. Monitor joint venture performance closely.
  2. Analyze the drivers of increased debt and reduced cash.
  3. Evaluate the sustainability of revenue growth.
  4. Assess the impact of asset sales or impairments.

Glossary

Unconsolidated Joint Ventures
Investments where the company has significant influence but does not have control, meaning the assets, liabilities, and results of these ventures are not fully included in the company's consolidated financial statements. Their performance is typically reported as equity income or loss. (A substantial equity loss from these ventures was a primary driver of the company's net loss in the current period.)
Gain (Loss) on Sales of Real Estate, net
The profit or loss realized from selling real estate properties. This is often a significant component of income for real estate companies. (A sharp decrease in this gain significantly impacted the company's profitability in the current quarter.)
Basic Earnings (Loss) per Common Share
The portion of a company's profit or loss allocated to each outstanding share of common stock. It is calculated by dividing net income (or loss) by the weighted-average number of outstanding shares. (The company swung from positive earnings per share in the prior year to a loss per share in the current period.)
Bank line of credit and commercial paper
Short-term borrowing facilities that allow a company to access funds as needed, often used for working capital or short-term financing needs. (An increase in borrowings under these facilities contributed to the rise in total liabilities.)
Senior unsecured notes
Debt instruments issued by a company that are not backed by specific collateral. They rank higher than subordinated debt but lower than secured debt in the event of bankruptcy. (An increase in the amount of these notes contributed to the company's higher total liabilities.)

Year-Over-Year Comparison

Healthpeak Properties reported a significant shift from net income to net loss, with a $117.1 million loss in Q3 2025 compared to an $85.9 million profit in Q3 2024. Total revenues saw a slight increase of 0.8% to $705.9 million, primarily due to higher resident fees. However, this was offset by a substantial equity loss from joint ventures ($176.3M vs $3.8M) and a sharp decline in gains on real estate sales ($11.5M vs $62.3M). Total liabilities increased by $436.5 million, while cash reserves decreased by $28.8 million, indicating a tightening financial position.

Filing Stats: 4,673 words · 19 min read · ~16 pages · Grade level 19.6 · Accepted 2025-10-24 16:16:29

Key Financial Figures

Filing Documents

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION Item 1.

Financial Statements (Unaudited)

Financial Statements (Unaudited): 3 Consolidated Balance Sheets 3 Consolidated Statements of Operations 4 Consolidated Statements of Comprehensive Income (Loss) 5 Consolidated Statements of Equity and Redeemable Noncontrolling Interests 6 Consolidated Statements of Cash Flows 8 Notes to the Consolidated Financial Statements 9 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 44 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 70 Item 4.

Controls and Procedures

Controls and Procedures 71

OTHER INFORMATION

PART II. OTHER INFORMATION Item 1A.

Risk Factors

Risk Factors 72 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 72 Item 5. Other Information 72 Item 6. Exhibits 73

Signatures

Signatures 75 2 Table of Contents

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

Financial Statements (Unaudited)

Item 1. Financial Statements (Unaudited) Healthpeak Properties, Inc. CONSOLIDATED BALANCE SHEETS (In thousands, except share and per share data) (Unaudited) September 30, 2025 December 31, 2024 ASSETS Real estate: Buildings and improvements $ 16,192,972 $ 16,115,283 Development costs and construction in progress 1,148,903 880,393 Land and improvements 2,927,571 2,918,758 Accumulated depreciation and amortization ( 4,438,273 ) ( 4,083,030 ) Net real estate 15,831,173 15,831,404 Loans receivable, net of reserves of $ 11,602 and $ 10,499 673,502 717,190 Investments in and advances to unconsolidated joint ventures 796,171 936,814 Accounts receivable, net of allowance of $ 1,933 and $ 2,243 80,845 76,810 Cash and cash equivalents 91,038 119,818 Restricted cash 68,694 64,487 Intangible assets, net 610,513 817,254 Assets held for sale, net 67,593 7,840 Right-of-use asset, net 417,365 424,173 Other assets, net 945,507 942,465 Total assets $ 19,582,401 $ 19,938,255 LIABILITIES AND EQUITY Bank line of credit and commercial paper $ 368,125 $ 150,000 Term loans 1,646,912 1,646,043 Senior unsecured notes 6,766,350 6,563,256 Mortgage debt 350,174 356,750 Intangible liabilities, net 155,557 191,884 Liabilities related to assets held for sale, net 12,371 — Lease liability 301,302 307,220 Accounts payable, accrued liabilities, and other liabilities 746,229 725,342 Deferred revenue 970,077 940,136 Total liabilities 11,317,097 10,880,631 Commitments and contingencies (Note 11) Redeemable noncontrolling interests 27,809 2,610 Common stock, $ 1.00 par value: 1,500,000,000 shares authorized; 694,946,444 and 699,485,139 shares issued and outstanding 694,946 699,485 Additional paid-in capital 12,765,070 12,847,252 Cumulative dividends in excess of earnings ( 5,854,766 ) ( 5,174,279 ) Accumulated other comprehensive income (loss) ( 7,975 ) 28,818 Total stockholders' equity 7,597,275 8,401,276 Joint venture partners 296,477 315,821 Non-manag

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing